Ling Morgan
About Ling Morgan
Ling Morgan serves as the Director of Bioanalytical & Biomarker Development at Wave Life Sciences, where she has worked since 2021. She has extensive experience in the bioanalytical field, having held various leadership roles at companies such as Shire, Takeda, and Agilux Laboratories.
Current Role at Wave Life Sciences
Ling Morgan serves as the Director of Bioanalytical & Biomarker Development at Wave Life Sciences. She has held this position since 2021, contributing to the company's focus on innovative therapies and drug development. Her role involves overseeing bioanalytical methods and biomarker strategies that support the advancement of therapeutic candidates.
Previous Experience in Bioanalysis
Before joining Wave Life Sciences, Ling Morgan worked at Takeda as Associate Director in the Center for Bioinformatics and Drug Development (CBID) from 2019 to 2021. Prior to that, she was the NCE Bioanalysis Lead at Shire from 2017 to 2019. Her experience includes significant roles at Agilux Laboratories, where she served as Associate Director and Principal Scientist III, focusing on GLP compliance and bioanalytical methods.
Educational Background in Chemistry
Ling Morgan earned her Doctor of Philosophy (Ph.D.) in Analytical Chemistry from The University of New Mexico, where she studied from 1992 to 1998. She also holds a Bachelor's Degree in Chemistry from Jilin University. This educational foundation has equipped her with the expertise necessary for her roles in bioanalytical and biomarker development.
Professional Journey in the Industry
Ling Morgan's professional journey includes various leadership roles in bioanalysis and laboratory management. She worked at Tandem Labs as a Group Leader from 2008 to 2010 and held multiple positions at Agilux Laboratories from 2010 to 2017. Her extensive experience spans over a decade in the biopharmaceutical industry, focusing on bioanalytical development and regulatory compliance.